Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury
- 1 April 2006
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 26 (3) , 346-351
- https://doi.org/10.1111/j.1478-3231.2005.01216.x
Abstract
Macrophage migration inhibitory factor (MIF) is involved in inflammatory and immune-mediated diseases but the role of MIF in liver injury has not yet been elucidated. We investigated biochemically, histologically and immunologically the character of MIF in concanavalin A (Con A)-induced T-cell-mediated liver injury using MIF knockout (KO) mice and wild-type (WT) mice. MIF KO mice showed significantly decreased serum alanine aminotransferase values and suppressed histological change with massive necrosis of the hepatic parenchymal cells and infiltration of inflammatory cells compared with their WT counterparts. This protection was not mediated by either tumor necrosis factor-alpha or interferon-gamma, which are critical mediators of Con A-induced liver injury, as their serum concentrations were shown to be similar in MIF KO and WT mice. On the other hand, a flow cytometric analysis demonstrated that the number of activated hepatic leukocytes decreased more in the MIF KO mice than in the WT mice. A lack of MIF protected the mice from Con A-induced liver injury. Controlling the MIF activity may be a useful therapeutic strategy for treating such T-cell activation-associated liver diseases as autoimmune hepatitis and viral hepatitis.Keywords
This publication has 29 references indexed in Scilit:
- Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infectionLiver International, 2005
- Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinomaInternational Journal of Cancer, 2003
- Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsivenessBiochemical and Biophysical Research Communications, 2002
- Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamineOncogene, 2002
- Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-γ-dependent mechanismHepatology, 2000
- Prevention of Lethal Acute Hepatic Failure by Antimacrophage Migration Inhibitory Factor Antibody in Mice Treated With Bacille Calmette–Guerin and LipopolysaccharideHepatology, 1999
- Concanavalin A-induced liver injury triggers hepatocyte proliferation.Journal of Clinical Investigation, 1998
- Production and role of interleukin-10 in concanavalin A-induced hepatitis in miceHepatology, 1997
- Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytesHepatology, 1995
- Mechanism of a Reaction in Vitro Associated with Delayed-Type HypersensitivityScience, 1966